Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.8 USD | -0.76% | +8.31% | -60.78% |
04-29 | Gritstone Bio, Inc. Announces Board Changes | CI |
04-15 | Nature Medicine Publishes Interim Results from Gritstone Bio's Phase 1/2 Study of "Off-The-Shelf" Neoantigen Vaccine Platform | CI |
Business Summary
Number of employees: 231
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Vaccine-based Immunotherapy
100.0
%
| 20 | 100.0 % | 16 | 100.0 % | -18.05% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 20 | 100.0 % | 16 | 100.0 % | -18.05% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Andrew Allen
FOU | Founder | 57 | 31/07/15 |
Director of Finance/CFO | 44 | 22/06/21 | |
Karin Jooss
CTO | Chief Tech/Sci/R&D Officer | 59 | 12/04/16 |
Erin Jones
COO | Chief Operating Officer | 52 | 30/04/16 |
Investor Relations Contact | - | 30/11/21 | |
James Cho
AUD | Comptroller/Controller/Auditor | - | 31/10/19 |
Human Resources Officer | - | - | |
Matthew Hawryluk
PRN | Corporate Officer/Principal | 46 | 31/10/15 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Andrew Allen
FOU | Founder | 57 | 31/07/15 |
Elaine Jones
CHM | Chairman | 69 | 11/09/19 |
Lawrence Corey
BRD | Director/Board Member | 77 | 11/08/22 |
Steve Krognes
BRD | Director/Board Member | 56 | 09/07/18 |
Naiyer Rizvi
FOU | Founder | 60 | - |
Shefali Agarwal
BRD | Director/Board Member | 50 | 31/05/21 |
Clare Fisher
BRD | Director/Board Member | 51 | 31/12/21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 105,918,748 | 103,482,823 ( 97.70 %) | 0 | 97.70 % |
Company contact information
Gritstone bio, Inc.
5959 Horton Street Suite 300
94608, Emeryville
+510 871 6100
http://www.gritstonebio.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-60.78% | 85.77M | |
-3.45% | 87.17B | |
+2.76% | 40.1B | |
-16.98% | 31.38B | |
+57.86% | 25.12B | |
-16.24% | 15.59B | |
-9.12% | 12B | |
-42.56% | 11.8B | |
-17.10% | 11.8B | |
+6.89% | 8.81B |
- Stock Market
- Equities
- GRTS Stock
- Company Gritstone bio, Inc.